Topic

Articles

While many voices are in agreement that the drive for diversity is both necessary and achievable—the question still remains: How do we actually start creating those meaningful conversations?

Steps Toward Diversity in Clinical Trials: Building Authentic Trust

Understanding the role of social determinants on clinical trial participation and trust.

Clinical Trials and Trust

Co-conveners of the newly formed Decentralized Trials & Research Alliance, Amir Kalali, MD and Craig Lipset discuss the alliance as well as how COVID-19 has impacted the industry.

New Alliance Seeks to Bring Increased Accessibility to Trials

Hybrid studies, patient-centric tools, and collaborations create big changes for clinical trials and stakeholders during COVID-19.

Sharpening the Focus on Patient-Centricity as Pandemic Continues

EVP and General Manager of Hū, April Lewis, discusses why the industry has seen a decline in trial participation and what Hū is doing to combat it.

Industry Forced to Rethink Patient Participation in Trials

Eliminating barriers to engage underrepresented populations.

Importance of Diversity in Parkinson’s Research

Randomized controlled trials establish strict inclusion and exclusion criteria in an effort to optimize the cohort of trial participants.

Real-World Evidence Studies can Enhance Diversity and Equity in Clinical Research

Recognizing pre-pandemic pain points, such as patient engagement and protocol development, could lead to post-pandemic trial success. 

Addressing the Needs of Clinical Trial Sites in a Post-COVID-19 World

Evaluating the lessons learned about trial sites from COVID-19 to form new strategies and improve patient safety for the future.

Shifting Perspectives on Site Networks to Create Positive Change

With the assistance of mobile research nursing, in-home visits provide solid alternative to trial participants, especially during COVID-19.